Atamyo Gene Therapeutics logo dark

Changing Lives of
Neuromuscular Patients
with Gene Therapy

Double DNA helix - ATAMYO Gene Therapy

Atamyo’s mission is to bring a new generation of best-in-class gene therapies to patients suffering from neuromuscular diseases

Read more

My goal is to be like everyone else and to have them forget my disability


Read Patient Stories

About Atamyo

The name of the company is derived from two words: Atao which means “Always” or “Forever” in a Celtic language and myo which is the Greek root for everything muscle-related. This name conveys the spirit of the company in its commitment to improve the life of patients affected by neuromuscular diseases with life-long efficient treatments.

Our Pipeline

At Atamyo, we use our expertise in gene therapy and muscular dystrophies to find new approaches for gene replacement.
Our goal is to design the best delivery system for a particular disorder, in order to decrease side effects and improve the restoring of a normal physiological function.

Read more

Diseases & Patient Communities

Limb girdle muscular dystrophies (LGMDs) are a group of rare genetic disorders characterized by a progressive dystrophic phenotype, mainly affecting the muscles of the shoulder and pelvic areas. Onset and severity of the symptoms are variable. Typical LGMD signs are difficulty in movements, wobbling gait and specific distribution of muscle atrophy.

Read more


The management team of Atamyo is seasoned team of professionals with extensive experience in biotech and gene therapy.

Read more

Latest News